Epitopea is a transatlantic cancer immunotherapeutics company.
Epitopea has raised $31.0M in total funding. The most recent round was Seed. The last funding was announced in October 2024.
Epitopea's investors include Fonds de solidarité FTQ, CTI Life Sciences Fund, Cambridge Innovation Capital, Investissement Quebec, Innovate UK.
Epitopea is headquartered in Cambridge, United Kingdom.
Epitopea is a transatlantic cancer immunotherapeutics company.
Epitopea is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Epitopea — Funding & Investors." VCBacked, October 24, 2024, https://www.vcbacked.co/company/epitopea. Accessed September 21, 2026.
VCBacked. (2024). Epitopea — Funding & Investors. Retrieved September 21, 2026, from https://www.vcbacked.co/company/epitopea
{{cite web |title=Epitopea — Funding & Investors |url=https://www.vcbacked.co/company/epitopea |website=VCBacked |access-date=September 21, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated